Skip to main content
Article
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
Journal for ImmunoTherapy of Cancer (2017)
  • Rachel E. Sanborn, Providence Portland Medical Center
  • Helen J. Ross, Mayo Clinic
  • Sandra Aung
  • Anupama Acheson, Providence Portland Medical Center
  • Tarsem Moudgil, Providence Portland Medical Center
  • Sachin Puri, Providence Portland Medical Center
  • Traci Hilton
  • Brenda Fisher, Providence Portland Medical Center
  • Todd Coffey, Providence Portland Medical Center
  • Christopher Paustian, Cleveland Clinic
  • Michael Neuberger, Ludwig Maximilian University of Munich
  • Edwin Walker, Providence Portland Medical Center
  • Hong Ming Hu, Providence Portland Medical Center
  • Walter J. Urba, Providence Portland Medical Center
  • Bernard A. Fox, Providence Portland Medical Center
Publication Date
January 12, 2017
DOI
10.1186/s40425-017-0306-6
Citation Information
Rachel E. Sanborn, Helen J. Ross, Sandra Aung, Anupama Acheson, et al.. "A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer" Journal for ImmunoTherapy of Cancer Vol. 5 Iss. 1 (2017) p. 103
Available at: http://works.bepress.com/walter-urba/103/